Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

COVID-19 research at MORU

Summary of the COVID research at MORU

COPCOV trial


COPCOV is a randomised, placebo-controlled prophylaxis study to determine whether chloroquine or hydroxychloroquine prevents coronavirus disease (COVID-19) in the healthcare setting.

SEBCOV study


SEBCOV aims to produce evidence to inform public health measures such as communications, quarantine, self-isolation, social distancing, travel restrictions and other for the COVID-19 pandemic.